Wagner Wealth Management, LLC Novo Nordisk A S Transaction History

Wagner Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$122.71 - $146.91 $9,816 - $11,752	80 Added 2.86%	2,878 $410,000
Q1 2024 Apr 23, 2024	BUY	$102.11 - $135.92 $8,577 - $11,417	84 Added 3.1%	2,798 $359,000
Q4 2023 Jan 19, 2024	BUY	$87.78 - $105.45 $238,234 - $286,191	2,714 New	2,714 $280,000
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $52,858 - $62,366	512 New	512 $57,000
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $52,508 - $63,472	-564 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$95.88 - $117.08 $5,848 - $7,141	61 Added 12.13%	564 $63,000
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $13,591 - $17,165	161 Added 47.08%	503 $55,000
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $22,934 - $25,930	342 New	342 $23,000

1,954

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Wagner Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wagner Wealth Management, LLC with notifications on news.